+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Beclomethasone"

From
Formoterol Fumarate API Market - Global Forecast 2025-2030 - Product Thumbnail Image

Formoterol Fumarate API Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 198 Pages
  • Global
From
Pulmonary Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Pulmonary Drugs Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 180 Pages
  • Global
From
Asthma Therapeutics Market Report 2025 - Product Thumbnail Image

Asthma Therapeutics Market Report 2025

  • Report
  • October 2025
  • 250 Pages
  • Global
From
Pulmonary Drugs Market Report 2025 - Product Thumbnail Image

Pulmonary Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Cough Hypersensitivity Syndrome Market Report 2025 - Product Thumbnail Image

Cough Hypersensitivity Syndrome Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
  • 8 Results (Page 1 of 1)
Loading Indicator

Beclomethasone is a corticosteroid drug used to treat respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). It is used to reduce inflammation in the airways, allowing for easier breathing. Beclomethasone is available in both inhaler and nebulizer forms, and is often prescribed in combination with other drugs. It is generally considered to be a safe and effective treatment for respiratory diseases. Beclomethasone is a widely used drug in the respiratory market, and is available from many pharmaceutical companies. Some of the major players in the market include GlaxoSmithKline, Merck, Sanofi, and Teva Pharmaceuticals. Other companies such as Mylan, Sun Pharmaceuticals, and Zydus Cadila also produce beclomethasone products. Show Less Read more